Commission Implementing Regulation (EU) 2019/724 of 10 May 2019 amending Implementing Regulation (EU) No 686/2012 as regards the nomination of rapporteur Member States and co-rapporteur Member States for the active substances glyphosate, lambda-cyhalothrin, imazamox and pendimethalin and amending Implementing Regulation (EU) No 844/2012 as regards the possibility that a group of Member States assumes jointly the role of the rapporteur Member State (Text with EEA relevance.)
Commission Implementing Regulation (EU) 2019/724 of 10 May 2019 amending Implementing Regulation (EU) No 686/2012 as regards the nomination of rapporteur Member States and co-rapporteur Member States for the active substances glyphosate, lambda-cyhalothrin, imazamox and pendimethalin and amending Implementing Regulation (EU) No 844/2012 as regards the possibility that a group of Member States assumes jointly the role of the rapporteur Member State (Text with EEA relevance.)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Amendments to Implementing Regulation (EU) No 686/2012
Implementing Regulation (EU) No 686/2012 is amended as follows:
(1)
Article 1 is replaced by the following:
‘Article 1
For the purposes of the renewal procedure, the evaluation of each active substance set out in the first column of the Annex is allocated either to a rapporteur Member State, as set out in the second column of that Annex, and to a co-rapporteur Member State, as set out in the third column of that Annex, or to a group of Member States acting jointly as rapporteur Member State, as set out in the fourth column of that Annex, where applicable. In the latter case, no co-rapporteur is appointed.’
(2)
The Annex is amended in accordance with the Annex to this Regulation.
Amendments to Implementing Regulation (EU) No 844/2012
Implementing Regulation (EU) No 844/2012 is amended as follows:
(1)
Paragraph 1 of Article 1 is amended as follows:
(a)
the first subparagraph is replaced by the following:
‘Without prejudice to the fourth subparagraph, an application for the renewal of an approval of an active substance shall be submitted by a producer of the active substance to the rapporteur Member State, as set out in the second column of the Annex to Commission Implementing Regulation (EU) No 686/2012 ( *1 ) and to the co-rapporteur Member State as set out in the third column of that Annex, or to each of the Member States in a group of Member States acting jointly as rapporteur Member State as set out in the fourth column of that Annex, no later than three years before the expiry of the approval.
( *1 ) Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances ( OJ L 200, 27.7.2012, p. 5 ).’;"
(b)
the following fourth, fifth and sixth subparagraphs are added:
‘Where a group of Member States jointly assumes the role of the rapporteur Member State as set out in the fourth column of the Annex to Implementing Regulation (EU) No 686/2012, no co-rapporteur Member State shall be appointed. In this case, all references to “the rapporteur Member State” in this Regulation shall be deemed to be references to “the group of Member States acting jointly as rapporteur Member State”.
Prior to the expiry of the deadline for submission of the application, the Member States acting jointly as rapporteur Member State shall agree on the repartition of all tasks and workload.
Member States forming part of the group of Member States acting jointly as rapporteur Member State shall endeavour to reach consensus during the evaluation.’;
(2)
in Article 11(2), point (h) is replaced by the following:
‘(h)
the points on which the co-rapporteur Member State did not agree with the assessment by the rapporteur Member State, where relevant, or, where applicable, the points where there is no agreement between Member States forming a group of Member States acting jointly as rapporteur Member State.’;
(3)
the following Article 13a is inserted:
‘Article 13a
Fees and charges
Member States may require payment of fees and charges in accordance with Article 74 of Regulation (EC) No 1107/2009 to recover the costs associated with any work they carry out within the scope of this Regulation.’
ANNEX
The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:
(1)
in Part B, the following fourth column is added with the heading:
‘Group of Member States acting jointly as rapporteur Member State (in alphabetical order in national language)’;
(2)
Part C is amended as follows:
(a)
the following fourth column is added with the heading: ‘Group of Member States acting jointly as rapporteur Member State (in alphabetical order in national language)’;
(b)
the following entry is inserted after the entry for Geraniol:
Active substance
Rapporteur Member State
Co-rapporteur Member State
Group of Member States acting jointly as rapporteur Member State (in alphabetical order in national language)
‘Glyphosate
FR, HU, NL, SE’
(c)
the following entry is inserted after the entry for Helicoverpa armigera nucleopolyhedrovirus (HearNPV):
Active substance
Rapporteur Member State
Co-rapporteur Member State
Group of Member States acting jointly as rapporteur Member State (in alphabetical order in national language)
‘Imazamox
EL
IT’
(d)
the entry for the active substance lambda-cyhalothrin is replaced by the following:
Active substance
Rapporteur Member State
Co-rapporteur Member State
Group of Member States acting jointly as rapporteur Member State (in alphabetical order in national language)
‘lambda-cyhalothrin
EL
FR’
(e)
the following entry is inserted after the entry for Paecilomyces fumosoroseus strain Fe9901:
Active substance
Rapporteur Member State
Co-rapporteur Member State
Group of Member States acting jointly as rapporteur Member State (in alphabetical order in national language)
‘Pendimethalin
SE
NL’
